Glucagon-like peptide 2

Trends in Endocrinology and Metabolism

Volumn 10, Issue 4, 1999, Pages 153-156

  Drucker, Daniel J ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON DERIVATIVE; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; HORMONE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CELL PROLIFERATION; DRUG MECHANISM; ENTERITIS; GLUCOSE TRANSPORT; HORMONAL THERAPY; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; INTESTINE CELL; INTESTINE CRYPT; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHORT BOWEL SYNDROME; TISSUE DISTRIBUTION;

EID: 0033020969     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00136-2     Document Type: Review

References (25)

1. Thim L., Moody A.J. The primary structure of porcine glicentin (proglucagon). Regul. Pept. 2:1982;139-150.
2. Jarrousse C., Niel H., Audousset-Puech M-P., Martinez J., Bataille D. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion. Peptides. 7:1986;253-256.
3. Mojsov S., Heinrich G., Wilson I.B., Ravazzola M., Orci L., Habener J.F. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J. Biol. Chem. 261:1986;11880-11889.
4. Orskov C., Holst J.J., Knuhtsen S., Baldissera F.G.A., Poulsen S.S., Nielsen O.V. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology. 119:1986;1467-1475.
5. Hoosein N.M., Gurd R.S. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett. 178:1984;83-86.
6. Drucker D.J. The glucagon-like peptides. Diabetes. 47:1998;159-169.
7. Gleeson M.H., Bloom S.R., Polak J.M., Henry K., Dowling R.H. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut. 12:1971;773-782.
8. Stevens F.M., Flanagan R.W., O'Gorman D., Buchanan K.D. Glucagonoma syndrome demonstrating giant duodenal villi. Gut. 25:1984;784-791.
9. Drucker D.J., Ehrlich P., Asa S.L., Brubaker P.L. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7911-7916.
10. Orskov C., Holst J.J. Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand. J. Clin. Lab. Invest. 47:1987;165-174.
11. Brubaker P.L., Crivici A., Izzo A., Ehrlich P., Tsai C-H., Drucker D.J. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide 2. Endocrinology. 138:1997;4837-4843.
12. Drucker D.J.et al. Regulation of the biological activity of glucagon-like peptide 2 by dipeptidyl peptidase IV. Nat. Biotechnol. 15:1997;673-677.
13. Fischer K.D., Dhanvantari S., Drucker D.J., Brubaker P.L. Intestinal growth is associated with elevated levels of glucagon-like peptide-2 in diabetic rats. Am. J. Physiol. 273:1997;E815-E820.
14. Cheeseman C.I., Tsang R. The effect of gastric inhibitory polypeptide and glucagon like peptides on intestinal hexose transport. Am. J. Physiol. 271:1996;G477-G482.
15. Cheeseman C.I. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am. J. Physiol. 273:1997;R1965-R1971.
16. Tsai C-H., Hill M., Asa S.L., Brubaker P.L., Drucker D.J. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice. Am. J. Physiol. 273:1997;E77-E84.
17. Drucker D.J., Deforest L., Brubaker P.L. Intestinal response to growth factors administered alone or in combination with h[Gly2]-glucagon-like peptide 2. Am. J. Physiol. 273:1997;G1252-G1262.
18. Drucker D.J., Yusta B., Boushey R.P., Deforest L., Brubaker P.L. Human [Gly2]-GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am. J. Physiol. 276:1999;G79.
19. Wojdemann M., Wettergren A., Hartmann B., Holst J.J. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand. J. Gastroenterol. 33:1998;828-832.
20. Tsai C-H., Hill M., Drucker D.J. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am. J. Physiol. 272:1997;G662-G668.
21. Brubaker P.L., Izzo A., Hill M., Drucker D.J. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am. J. Physiol. 272:1997;E1050-E1058.
22. Drucker D.J. Intestinal growth factors. Am. J. Physiol. 273:1997;G3-G6.
23. Chance W.T., Foley-Nelson T., Thomas I., Balasubramaniam A. Prevention of parenteral nutrition-induced gut hyoplasia by coinfusion of glucagon-like peptide-2. Am. J. Physiol. 273:1997;G559-G563.
24. Scott R.B., Kirk D., MacNaughton W.K., Meddings J.B. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am. J. Physiol. 275:1998;G911-G921.
25. Munroe D.G.et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1569-1573.